Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Priel and ARX buy Slovenian diagnostic hospital

Healthcare investor and entrepreneur, Joseph Priel, and private equity firm, ARX Partners, have purchased Slovenian hospital DCB (Diagnostic Centre Bled) from family owners. This is believed to be the first big private healthcare services deal in the country. Priel's businesses are now active in at least four countries.

Lab groups spread across the African continent

The middle classes in sub-Saharan Africa are increasingly willing to pay for quality lab tests and a growing number of companies are supplying them. Larger groups are overcoming the challenges of opening labs in the continent and now have networks spanning 12 countries. We spoke to leading operators about the opportunities and challenges in African labs.

FREE BLOG Why healthcare services needs to think about total cost of ownership

Healthcare service operators of all sorts have failed, at least until very recently, to measure and manage the total cost of ownership. That is odd because TCO models, in which you measure the real costs of operating, can massively improve EBITDA, particularly for capital equipment. It can also be adapted to measure and improve entire facilities - see our interview with Patrick Gontard below. He claims that TCO in labs can grow EBITDA by 10-15 percentage points. Similar gains can probably be made in imaging, for instance.

Interview: Patrick Gontard, CEO, Citilab, CEO and Founder, Gontard & Cie

Total cost of ownership (TCO) models have increased EBITDA margins by 10-15 percentage points in the lab sector and can be used in any area of healthcare, says Gontard. A Swiss economist, he has perfected his model over 15 years, working first for Viollier, the second largest Swiss lab group, then at Integrated Diagnostics in Egypt and now at Citilab probably the second largest lab group in Russia. Gontard is speaking on TCO at Healthcare Europa 2015 on April 28 in London.

How POCT can massively improve efficiency in acute care

Point of Care Testing can massively reduce hospital stay costs, according to a recent UK pilot. Early signs suggest diagnostics will grow as a sector and POCT will come to dominate a limited share of the market. But could the established labs make use of innovations in POCT and are there unforeseen consequences for the rest of healthcare services? Last week we talked to consultants and operators on either side of the POCT debate. Now we look at what effect POCT is having on the wards, talk to manufacturers and hear from Eric Souetre, founder and major shareholder of Labco.

Is IDH rethinking its IPO?

Egyptian lab group, Integrated Diagnostics holdings, could be reconsidering the structure of its IPO. IDH sold a 21% stake to an unnamed European investor before Christmas said well-placed sources.

Apollo backs cancer diagnostic group

Sapien Biosciences, backed by India’s Apollo Hospitals, has entered into collaboration with Bangalore-based diagnostic start-up OncoStem Diagnostics to develop a breast cancer recurrence prediction test.

Lifebrain hoovers up Italian labs

Austrian lab group Lifebrain has completed a new bout of acquisitions across Italy. Three labs have been added to its fold: Salus in Lazio, Euromedical & Lab in Bologna, and Biomedical in Puglia.

Report: Is POCT a threat to the diagnostic lab sector?

POCT (Point-of-Care-Testing) has been heralded as the next frontier in medical diagnostics. Together with Theranos, the new US innovator, it is also often portrayed as a threat to the traditional lab landscape. Is it?

Diagnostics set to rocket in Africa

The lab and imaging services are set to soar across Africa, according to delegates and speakers at Africa Healthcare Summit 2015. New chains are growing fast in most countries, sometimes backed by major medtech players. And there is a huge international trade in esoteric tests. Meanwhile GE Healthcare has all but doubled sales in three years. We look at who is who and where.

Find Us